News

Kyle Arteaga is CEO of The Bulleit Group. He helps founders get seen in AI search by building visibility in the model’s ...
Explore ChatGPT 5’s groundbreaking new features, from debugging code to creating apps, and see how it’s reshaping the future ...
The Samsung Galaxy Z Fold 7 brings a refined design, bigger screen and upgraded main camera. Find out its pros, cons and how ...
OpenAI might’ve deprecated o3 during its GPT-5 launch yesterday, but the model has made the company proud on its way out.
Available to all users today. GPT-5 is OpenAI’s most advanced AI model to date, and it's now officially launched to all users. It comes in four ...
Strong, continued tech spending on artificial intelligence should be great news for Marvell's growth prospects.
The best Stratechery content from the week of August 4, 2025 including what Nokia can teach us about the AI era, what the NFL wants from ESPN, and how Visa conquered debit cards.
aTyr's lead drug, efzofitimod, just completed enrollment in its phase 3 EFZO-FIT trial for pulmonary sarcoidosis, with results expected in 2025's third quarter. Since EFZO-FIT is a single phase 3 ...